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Abstract
Background—COPD is characterized by reduced airway lumen dimensions and fewer
peripheral airways. Most studies of airway properties sample airways based upon lumen
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dimension or at random, which may bias comparisons given reduced airway lumen dimensions
and number in COPD. We sought to compare central airway wall dimensions on computed
tomography (CT) in COPD and controls using spatially matched airways, thereby avoiding
selection bias of airways in the lung.
Methods—The MESA COPD Study and SPIROMICS recruited smokers with COPD and
controls aged 50–79 years and 40–80 years, respectively. COPD was defined by current
guidelines. Using CT image data, airway dimensions were measured for all central airway
segments (generations 0–6) following 5 standardized paths into the lungs. Case-control airway
comparisons were spatially matched by generation and adjusted for demographics, body size,
smoking, CT dose, percent emphysema, airway length, and lung volume.
Results—Among 311 MESA COPD participants, airway wall areas at generations 3–6 were
smaller in COPD compared to controls(all p<0.001). Among 1248 SPIROMICS participants,
airway wall areas at generations 1–6 were smaller(all p<0.001), and this reduction was monotonic
with increasing COPD severity(P<0.001). In both studies, sampling airways by lumen diameter or
randomly resulted in a comparison of more proximal airways in COPD to more peripheral airways
in controls(p<0.001) resulting in the appearance of thicker walls in COPD(p<0.02).
Conclusions—Airway walls are thinner in COPD when comparing spatially matched central
airways. Other approaches to airway sampling result in comparisons of more proximal to more
distal airways and potentially biased assessment of airway properties in COPD.
Keywords
Chronic obstructive pulmonary disease; computed tomography; airways; walls
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is defined by persistent airflow limitation
and is a leading cause of morbidity and mortality in the US and globally.[1] Understanding
the pathophysiology of COPD requires understanding of the relationship between airway
structure and function. Airflow limitation is determined in part by the resistive properties of
the tracheobronchial tree, which is a three-dimensional branching structure.[2] Weibel’s
classic study of human lung morphometry demonstrated that airway dimensions vary
according to the spatial location within the tracheobronchial tree.[3] Therefore, it is likely
that the study of airway properties in COPD requires accurate anatomic localization and
comparison of spatially equivalent airways in order to provide unbiased results.[4]
Studies accounting for spatial differences in airway dimensions on pathological section or
computed tomography (CT) have consistently demonstrated reduced airway lumen
dimensions and fewer peripheral airways in COPD.[5–12] Multiple histologic and CT
studies have reported thicker airway walls in COPD.[10 12–17] However, these studies
sampled airways either based upon lumen diameter or randomly within the identified
airways in the lung. If COPD is characterized by reduced airway lumen size and fewer distal
airways, such sampling is likely to lead to a comparison of more proximal airways in cases
of COPD compared to controls. Such a comparison may introduce a selection bias that
would yield erroneous conclusions of thickened airway walls in COPD.
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In order to avoid selection bias in the study of airways in COPD, our objective was to
compare central airway wall dimensions in COPD and controls that were matched spatially
by generation number and anatomical name (e.g., lobar bronchi, segmental bronchi) in two
multicenter case-controls studies of COPD, one of milder disease recruited predominantly
from the general population and the other of more severe disease recruited predominantly
from the subspecialist setting. In addition, we repeated the analyses of airway walls using
potentially biased approaches, i.e., sampling airways by lumen diameter or randomly.
Finally, we examined the implications of reduced airway lumen caliber and number in
COPD for the validity of the Pi10, a derived measure commonly used to study wall
thickness in COPD.[5 12 15–18]
Preliminary results were presented in abstract form.[19]
METHODS (See Web Supplement for Additional Details and References)
Study participants
The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study recruited cases of COPD
and controls predominantly from MESA, a population-based prospective cohort study of
subclinical atherosclerosis, a non-overlapping lung cancer screening study, and the
outpatient community at Columbia University Medical Center. Participants were 50–79
years of age with ≥10 pack-year smoking history. Exclusion criteria were clinical
cardiovascular disease, stage IIIb–V chronic kidney disease, asthma prior to age 45 years,
prior lung resection, contraindication to magnetic resonance imaging, and pregnancy.
The Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) is recruiting
participants 40–80 years of age with >20 pack-year smoking history with COPD and
controls with >20 pack-year smoking history, as well as never smokers.[20] Exclusion
criteria include other chronic lung diseases except asthma (e.g., sarcoidosis, interstitial lung
disease), body mass index (BMI) >40 kg/m2, prior lung resection, metal in the chest (e.g.,
pacemaker) and pregnancy. The present analysis was performed on the first 1278 current or
former smokers completing the baseline evaluation.
Study protocols were approved by the institutional review board of participating institutions
and by the National Heart, Lung, and Blood Institute. Written informed consent was
obtained from all participants.
Chest computed tomography (CT) acquisition and analysis
All participants in both studies underwent full-lung thoracic CT on 64 or 128-slice helical
scanners (120 kVp, 0.625–0.75 mm slice thickness, 0.5 sec. rotation time). Scans were
acquired with milliamperes (mA) set by BMI to maintain a consistent volume CT dose index
(6.1, 7.6, 11.4 mGy respectively). Images were obtained at suspended full inspiration.
Airway dimensions were assessed at a single reading center for both studies blinded to other
participant information.
The central airway tree was identified using Apollo Software (VIDA Diagnostics,
Coralville, Iowa). Airways were labeled anatomically from trachea to subsegmental bronchi
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along five pre-specified paths: RB1, RB4, RB10, LB1, and LB10. Segmentation and
labeling were visually verified by a dedicated image analyst and all labeled airways were
assigned a generation number based upon the number of branch points from the trachea,
which was assigned generation 0. Cross-sectional airway wall area and wall thickness, as
well as lumen area, diameter, and perimeter were measured perpendicular to the local airway
segment’s long axis using a subvoxel resolution algorithm in the Apollo Software, within an
image plane, and measurements were averaged along the middle third of each labeled
airway segment. Airway length was measured as the distance between branch points.
Percent wall area was calculated for each airway as the ratio of wall area to the sum of wall
and lumen area, multiplied by 100. Pi10 was calculated by regressing the square-root wall
area on internal perimeter of included airways to predict the square-root wall area of a single
hypothetical airway with internal perimeter of 10 mm. A Pi10 was calculated for each
participant using all measured airways, as well as using airways from each generation with
five or more airways. Airway counts were determined by software summing all visually-
confirmed airway segments detected along the five pre-specified paths and stratified by
lumen diameter.. Intra-class correlation coefficients for reproducibility of airway measure in
the MESA COPD Study were 0.79–0.99, 0.74–0.99 and 0.78–0.96 for wall area, lumen area,
and airway count, respectively (Web Supplement Tables E1–E2).
Lung volumes were quantified from segmented lung images. Percent emphysema-like lung
was defined as the percentage of total voxels within the lung field <−950 Hounsfield units
(percent emphysema−950HU).
Spirometry
Post-bronchodilator spirometry was performed following American Thoracic Society
recommendations on a dry-rolling-sealed spirometer in MESA COPD and a
pneumotachograph spirometer in SPIROMICS. Predicted spirometry values were calculated
using Hankinson reference equations.[21] COPD was defined as post-bronchodilator ratio of
forced expired volume in one second to forced vital capacity (FEV1/FVC) less than 0.7 and
spirometric severity as mild (FEV1≥80% predicted), moderate (50%≤FEV1<80% predicted),
severe (30%≤FEV1<50% predicted), and very severe (FEV1<30% predicted).[1] Controls
had a post-bronchodilator FEV1/FVC>0.7 and an FVC above the lower limit of normal.
Anthropometry and other co-variates
Age, gender, and race-ethnicity were self-reported, and height and weight were measured
following standardized protocols. Smoking history was assessed using standard
questionnaire items; current smoking status was confirmed with urine or plasma cotinine
levels in MESA COPD.
Statistical analysis
The MESA COPD and SPIROMICS data were examined separately because the former
recruited predominantly from the general population with milder disease, and the latter
recruited from the subspecialist setting with more severe disease. Dichotomous variables are
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presented as proportions and continuous variables as means with standard deviation unless
otherwise indicated.
The primary analysis compared central airway wall areas among participants with COPD to
controls stratified spatially by generation number. All airways in the pre-specified paths of a
given generation were included in the analyses. Within-generation generalized estimating
equations with exchangeable covariance matrix structure and robust standard errors were
used to account for multiple airway measures per participant;[22] and linear regression to
adjust for age, gender, height, BMI-determined CT dose, race-ethnicity, current smoking
status, airway length, percent emphysema−950HU, and lung volume achieved at CT. Height
and lung volume were included to normalize body size and to account for lung
hyperinflation and depth of inspiration at CT, which may influence airway wall dimensions.
[23] Sensitivity analyses modelled percent predicted FEV1 and FVC, and stratified by
anatomic name as an alternate method of comparing spatially matched airways, and by
COPD severity. Airway lumen areas and percent wall areas were also compared according
to COPD status by generation number adjusting for the same covariates.
To assess the potential bias of alternative sampling methods, secondary analyses compared
airway wall areas in COPD and controls selected based upon airway lumen diameter, as well
as randomly sampled (n=15 airways) from each participant, and adjusting for the same
covariates. Comparison of the spatial location of airways sampled by these methods
according to COPD status was assessed using the χ2-test. The number of observed airways
within lumen diameter strata was compared according to COPD status. Finally, Pi10 was
calculated for each participant using all airways, as well as for airways from each
generation, and compared with respect to COPD status. Calculation of Pi10 required 5 or
more airway wall measures per participant; therefore, Pi10 was not calculated for
generations 0 to 2.
All calculations were performed using SAS 9.3 (Cary, NC) with a hypothesis testing alpha
level of 0.05.
RESULTS
Of 329 participants enrolled in the MESA COPD Study, 311 had visually confirmed spatial
mapping of the tracheobronchial tree. Similarly, 1248 of the 1278 SPIROMICS participants
had visually confirmed mapping of the tracheobronchial tree. Participants included in the
analyses were similar to those with incomplete measures except for differences in severity of
airflow obstruction (Web Supplement Table E3).
Clinical characteristics of included participants by COPD status are summarized in Table 1.
The MESA COPD Study participants had a mean age of 68±7 years with 37±24 pack-years
of smoking. Forty-seven percent of participants had COPD that was predominantly
moderate in severity. The SPIROMICS sample had mean age of 65±9 years, 50±24 pack-
years of smoking, and more severe COPD. In both studies, the prevalence of white race-
ethnicity and number of pack-years of smoking were greater among participants with COPD
compared to controls.
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The number of detectable airways with lumen diameter between 2.5 and 4.0 mm was
reduced in COPD compared to controls in both studies (Table 1), and this difference was
independent of age, gender, height, BMI-determined CT dose, race-ethnicity, smoking
status, percent emphysema−950HU, and lung volume (p<0.001).
Central airway lumen size was significantly smaller in COPD compared to controls in both
cohorts, and this was independent of covariates (Web Supplement Table E4). Consistent
observations were made for percent predicted FEV1 and FVC (Web Supplement Table E5).
Airway wall areas in COPD: spatially matched central airways
Table 2 summarizes mean airway wall areas according to airway generation number and
differences between COPD and controls. In the MESA COPD Study, generation 4 to 6
airway wall areas were significantly smaller in COPD compared to controls in crude
comparisons (p≤0.01 for all). In adjusted comparisons (Figure 1), these differences remained
significant (p<0.001 for all), and extended to generations 1 and 3 (p≤0.005 for both). Similar
associations between airway wall area and COPD status were obtained when matching by
anatomic name (Web Supplement Table E6), or using airway wall thickness instead of wall
area (Web Supplement Table E7).
In SPIROMICS, generation 4 to 6 airway wall areas were significantly smaller in COPD
compared to controls (Table 2). In adjusted comparisons, these differences were observed at
generations 1 through 6 (Table 2), and remained significant with matching by anatomic
name (Web Supplement Table E6), or using airway wall thickness (Web Supplement E7).
Compared to controls, greater COPD severity was associated with monotonically thinner
airway wall areas from generation 0 to 6 in SPIROMICS (Figure 2).
Similar associations were observed between airway wall area and percent predicted FEV1
and FVC in both cohorts (Web Supplement Table E8).
Percent wall area was significantly greater in COPD compared to controls in both cohorts,
and independent of covariates (Web Supplement Table E9). Consistent observations were
made using percent predicted FEV1 and FVC (Web Supplement Table E10). These
associations, when combined with the above observations of smaller airway wall and lumen
dimensions in COPD, imply proportionally smaller lumen area compared to wall area.
Airway wall areas in COPD assessed with alternative approaches to airway sampling
When airways were selected according to lumen diameter in the MESA COPD Study, a
significantly greater proportion of proximal airways in COPD compared to controls was
observed for airways 2.5 to 4.0 mm in diameter (Global χ2: p<0.001). Similar results were
observed for airways of lumen diameter 4.0 to 5.5 mm, and 5.5 to 7 mm (Global χ2: p≤0.01
for both) in the MESA COPD Study. In SPIROMICS, a greater proportion of proximal
airways in COPD compared to controls were observed for airways of lumen diameter 2.5 to
4.0 mm, 4.0 to 5.5 mm, 5.5 to 7.0 mm, 7.0 to 8.5 mm, and 8.5 to 10.0 mm (Global χ2:
p<0.001 for all).
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In both MESA COPD and SPIROMICS, airways selected based upon lumen size yielded
associations of greater wall area in COPD in unadjusted and adjusted comparisons for
airways of lumen diameter 2.5 to 4.0 mm, 4.0 to 5.5 mm, and 5.5 to 7.0 mm (p<0.001 for
all; Table 3).
When fifteen airways were selected randomly from the observed airways for each
participant, a significantly greater proportion of proximal airways were selected in COPD
cases compared to controls in MESA COPD and SPIROMICS (Global χ2: p≤0.01 for both).
Analyses using these airways sampled randomly from observed airways also resulted in
larger wall areas in COPD compared to controls (Table 4).
Pi10 in COPD
Achieving an unbiased comparison of Pi10 when the spatial distribution of sampled airways
differs requires that the ratio of square-root wall area to lumen perimeter is similar across the
sampled range of generations. In both MESA COPD and SPIROMICS, however, significant
differences in this ratio were observed (Kruskal-Wallis: p<0.001 for both).
Hence, calculation of Pi10 among spatially matched airways should yield an unbiased
estimate of the Pi10. Indeed, spatial matching by generation number resulted in significantly
smaller Pi10 in COPD compared to controls for generations 4 to 6 in MESA COPD (p<0.03
for all) and SPIROMICS (p≤0.01 for all; Figure 3).
In contrast, calculating Pi10 from all measured airways yielded results suggesting increased
wall dimensions in COPD compared to controls in both MESA COPD and SPIROMICS
(p<0.001 for both; Figure 3).
DISCUSSION
In two independent studies of smokers, COPD was associated, on average, with significantly
smaller airway wall areas on CT compared to controls when central airways were matched
spatially based on generation number or anatomic name. Analysis of airways sampled on
lumen diameter or sampled randomly from observed airways resulted in a comparison of
more proximal airways in COPD compared to controls, thus introducing a selection bias and
suggesting larger wall areas in COPD. Results for the Pi10 were similar. In addition to the
observed reduction of airway wall thickness, these results suggest that studies of airway wall
morphology, histology and genomics should compare spatially matched airways in COPD
cases compared to controls.
The present study is the first to compare commonly used airway sampling techniques to
study airway wall dimensions in COPD. Consistent with our observation, the COPDGene
Study also observed significantly smaller central airway wall areas when comparing
anatomically matched airway segments.[24] In contrast, several studies have suggested
thicker walls in COPD.[10 12–17 25] We suspect these associations may have been biased,
however, due to sampling from different locations in the tracheobronchial tree depending on
disease status, a bias that we replicate in the current study. Airway wall and lumen
dimensions, as well as the ratio of square-root wall area to lumen perimeter, differ
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significantly by generation number,[3] which, we found, results in a differential spatial
distribution of airways by COPD status when airways are sampled by lumen diameter or
randomly. Applying these biased sampling techniques in the present study yielded results
suggesting thicker airway walls in COPD.
Wall-lumen ratio measures (e.g., percent wall area) have been reported to be increased in
COPD,[6–8 23] which has been interpreted by some as evidence that airway wall thickening
encroaches upon and narrows airway lumens in COPD. Without comparing absolute airway
dimensions, this inference assumes that total airway calibers are similar in COPD and
controls. However, consistent with the COPDGene cohort,[24] we show that both wall and
lumen areas are reduced in COPD compared to controls, although the difference is greater in
lumen size, a finding which is likely of greater physiologic importance to airflow limitation.
The mechanism underlying the observed smaller wall areas in COPD was not the primary
focus of this paper. However, differences in lung volume due either to COPD-related
hyperinflation or submaximal inspiration at the time of CT do not appear to explain our
findings.[23] Smaller wall areas in COPD were consistently observed with adjustments for
lung volume achieved at CT, as well as airway-specific length, suggesting that the airways
were not merely stretched and therefore thinner.
Other potential mechanisms include regression of airway smooth muscle resulting from
reduced wall tension, apoptosis or replacement fibrosis resulting from chronic airways
inflammation, or reduced bronchial vascular volume.[26 27] We did not assess airway wall
histology in the present study. Therefore, some components of the airway wall may be
increased in COPD.[5 25] Finally, we present differences in means, which suggests that
most people with COPD have thinner airways but does not rule out the possibility of a
subset having thicker airway walls.
Our analyses did not include many airways less than 2mm in lumen diameter, a threshold
below which many believe the excess airways resistance arises in COPD.[28 29] This was
due in part to CT resolution[9], as well as the technical demands of visually-confirmed
spatial mapping of the tracheobronchial tree to the sixth generation in large studies.
However, the classic studies[28 29] that describe airways less than 2mm as the predominant
site of resistance in COPD may have been subject to the same bias described here:
comparison of peripheral and central resistance when a fixed-diameter catheter may have
wedged more proximally in COPD could bias inferences related to the site of airways
obstruction. Central airways likely also contribute to airways resistance in COPD, as
demonstrated by Yanai[29] and Macklem.[30] Nevertheless, histologic confirmation of
fewer and thinner central airways, as well as a method of spatially matching peripheral
airways is needed.
Alternative approaches to matching airways in COPD based on histologic characteristics
(e.g., membranous,[18] cartilaginous,[5] or terminal bronchioles[9]) were not addressed in
this paper. However, these histologically defined airways span multiple generations,[3] thus
bias resulting from sampling of more proximal airways with similar histologic
characteristics in COPD cannot be excluded.
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Airway segments occluded by mucous may have gone undetected by the imaging software.
We do not believe such a sampling bias contributed to our findings, however, given the
association between increasing COPD severity and thinner walls was also observed in
proximal airways (e.g., mainstem and lobar bronchi) where complete mucous occlusion is
unlikely and spatial mapping reproducibility was excellent.[31]
In summary, in two independent studies of smokers, COPD was associated with
significantly less airway wall thicknesses throughout most of the central tracheobronchial
tree when comparing spatially matched airways. Sampling airways by lumen diameter or
randomly resulted in differential spatial distributions by COPD status and introduced
selection bias in the study of airway wall properties, as did the use of the Pi10. Studies of
airway morphometry, histology and genomics in COPD should spatially match airways to
avoid potentially large selection bias due to comparison of proximal-to-peripheral airways.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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What is the key question? Are airway walls thicker or thinner in COPD?
What is the bottom line? Airway walls are thinner in COPD when comparing spatially
matched central airways.
Why read on? We demonstrate that techniques commonly used to study airway wall
properties in COPD, such as sampling airways based upon lumen diameter or at random,
results in a biased comparison of more proximal airways in COPD to more peripheral
airways in controls.
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Figure 1. Airway Wall Area According to COPD Status Stratified by Generation Number in the
MESA COPD Study
*p<0.05 for within-generation comparison of mean wall area between participants with no
COPD to those with COPD. Mean values and differences adjusted for age, gender, height,
race-ethnicity, smoking status, airway length, percent emphysema−950HU, BMI-determined
CT dose, and lung volume at CT.
Abbreviations: COPD denotes chronic obstructive pulmonary disease, MESA Multi-Ethnic
Study of Atherosclerosis, CI confidence interval, HU Hounsfield units, BMI body mass
index, and CT computed tomography.
Smith et al. Page 12






















Figure 2. Airway Wall Areas According to COPD Severity Stratified by Generation Number in
SPIROMICS
*p<0.05 for within-generation comparison of airway wall area between participants with no
COPD to those with the COPD severity indicated. Mean values and differences adjusted for
age, gender, height, race-ethnicity, smoking status, airway length, percent
emphysema−950HU, BMI-determined CT dose, and lung volume at CT.
Abbreviations: COPD denotes chronic obstructive pulmonary disease, SPIROMICS
Subpopulations and Intermediate Outcome Measures in COPD Study, HU Hounsfield units,
BMI body mass index, and CT computed tomography.
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Figure 3. Pi10 According to COPD Status in SPIROMICS
*p<0.05 for comparison of mean Pi10 between participants with no COPD to those with
COPD. Calculation of Pi10 required 5 or more airways per participant; therefore, Pi10 was
not computed for generations 0 to 2. Mean values and differences adjusted for age, gender,
height, race-ethnicity, smoking status, airway length, percent emphysema−950HU, BMI-
determined CT dose, and lung volume at CT.
Abbreviations: COPD denotes chronic obstructive pulmonary disease, SPIROMICS
Subpopulations and Intermediate Outcome Measures in COPD Study, CI confidence
interval, HU Hounsfield units, BMI body mass index, and CT computed tomography.
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Table 1










Age –year 68±7 68±7 61±10 66±8
Male – % 54 66 46 59
Race-ethnicity – %
  White 45 62 70 84
  Black 25 28 26 12
  Other 30 10 5 5
Height – cm 167±9 171±9 170±10 171±10
Weight – kg 80±17 80±19 83±18 80±17
Smoking status – %
  Former 77 67 54 68
  Current 23 33 46 32
Pack-years 32±19 44±32 43±21 54±25
Percent predicted FEV1 100±16 74±19 95±14 62±23
FEV1/FVC 78±5 58±11 87±5 51±13
COPD GOLD severity – %
  Mild (FEV1≥80% predicted) - 39 - 24
  Moderate (50% ≥ FEV1 < 80% predicted) - 47 - 44
  Severe (30% ≥ FEV1 < 50% predicted) - 12 - 23
  Very severe (FEV1<30% predicted) - 1 - 9
Lung volume at CT – L 4.2±1.1 4.8±1.2 5.3±1.2 6.3±1.4
Percent emphysema−950 HU – median (IQR) 1.2 (1.8) 4.5 (7.7) 0.9 (1.7) 6.9 (14)
No. of airways per participant – median (1st, 3rd quartile)
  Lumen diameter > 11.5 mm 2 (2, 3) 2 (2, 3) 2 (2, 3) 2 (2, 3)
  10.0 mm < lumen diameter ≤ 11.5 mm 1 (1, 2) 1 (1, 2) 1 (1, 2) 1 (0, 2)
  8.5 mm < lumen diameter ≤ 10.0 mm 2 (1, 2) 2 (1, 2) 2 (1, 3) 2 (1, 2)*
  7.0 mm < lumen diameter ≤ 8.5 mm 3 (2, 4) 3 (2, 3)* 3 (2, 4) 3 (2, 4)*
  5.5 mm < lumen diameter ≤ 7.0 mm 4 (3, 5) 4 (2, 5)* 3 (2, 5) 3 (2, 4)*
  4.0 mm < lumen diameter ≤ 5.5 mm 7 (6, 10) 7 (5, 8)* 8 (6, 10) 6 (4, 8)*
  2.5 mm < lumen diameter ≤ 4.0 mm 28 (20, 38) 19 (14, 27)* 34 (24, 44) 20 (15, 28)*
Lumen diameter – mm
  Generation 0 16.0±2.3 16.5±2.6 16.7±2.4 16.4±2.5
  Generation 1 12.0±1.9 12.0±1.9 12.6±2.1 12.3±2.0
  Generation 2 8.5±1.6 8.4±1.6 8.8±1.5 8.6±1.6
































  Generation 3 6.1±1.5 5.7±1.5* 6.3±1.6 6.0±1.6*
  Generation 4 4.4±1.4 4.1±1.3* 4.7±1.7 4.3±1.5*
  Generation 5 3.2±1.0 3.0±1.0* 3.4±1.0 3.1±1.0*
  Generation 6 2.6±0.9 2.5±1.0* 2.7±0.9 2.5±0.8*
Plus-minus values are means±SD.
*
p<0.05 for comparison between COPD and controls of airway lumen diameter (Student t-test) or number of airways per participant (Pearson χ2-
test).
Abbreviations: MESA denotes Multi-Ethnic Study of Atherosclerosis, SPIROMICS Subpopulations and Intermediate Outcome Measures in COPD
Study, COPD chronic obstructive pulmonary disease, FEV1 forced expired volume in the first second, FVC forced vital capacity, GOLD Global
Initiative for chronic Obstructive Lung Disease, CT computed tomography, HU Hounsfield units, IQR inter-quartile range, and SD standard
deviation.
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Table 4
Airway Wall Areas According to COPD Status from 15 Randomly Selected Airways per Participant.
MESA COPD Fifteen randomly selected airways per participant
Unadjusted mean airway wall area in mm2
  COPD 19.9
  No COPD 18.2
  Difference





Mean airway wall area in mm2 adjusted for age, gender, height, race-ethnicity, smoking status, airway length, percent emphysema−950HU, BMI-
determined CT dose, and lung volume at CT
  COPD 18.8
  No COPD 17.7
  Difference





SPIROMICS Fifteen randomly selected airways per participant
Unadjusted mean airway wall area in mm2
  COPD 17.7
  No COPD 17.0
  Difference





Mean airway wall area in mm2 adjusted for age, gender, height, race-ethnicity, smoking status, airway length, percent emphysema−950HU, BMI-
determined CT dose, and lung volume at CT
  COPD 17.7
  No COPD 17.1
  Difference





Mean values and differences, along with 95% CI and p-values were estimated using linear regression with generalized estimating equations.
Abbreviations: COPD denotes chronic obstructive pulmonary disease, MESA Multi-Ethnic Study of Atherosclerosis, SPIROMICS Subpopulations
and Intermediate Outcome Measures in COPD Study, HU Hounsfield units, BMI body mass index, CT computed tomography, and CI confidence
interval.
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